Serial #79399433
LIVE

Serial Number

79399433

Owner

KOWA COMPANY LTD.

Filing Date

Jun 3, 2024

Add to watchlist:

No watchlists yet
View on USPTO

Serial #79399433 Trademark

Serial Number: 79399433 • Registration: 7910106

Serial #79399433 is a trademark filed by KOWA COMPANY LTD. on June 3, 2024. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

KOWA COMPANY LTD. (417 trademarks)

NO. 4-14 CHOME
TOKYO 103 , JP

Entity Type: 03

Trademark Details

Filing Date

June 3, 2024

Registration Date

August 26, 2025

Published for Opposition

June 10, 2025

Goods & Services

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of diseases of the circulatory system and diabetes-related diseases, pharmaceutical preparations for treatment of fatty liver and steatohepatitis, pharmaceutical preparations for the treatment of cardiovascular disorders and metabolic disorders, pharmaceutical preparations for the treatment of digestive system disease, pharmaceutical preparations for the treatment of primary biliary cirrhosis, pharmaceutical preparations for the treatment of fatty liver and liver hepatitis and liver cirrhosis, pharmaceutical preparations for the treatment of liver disease, pharmaceutical preparations for the treatment of metabolic disease, pharmaceutical preparations for the prevention and treatment of disorders of the metabolic system, analgesics; pharmaceutical and biological preparations for the treatment of diseases of the central nervous system, peripheral nervous system, sensory organs, the circulatory system, respiratory system, and the digestive system; pharmaceutical substances for the treatment of dermatological diseases, allergies and urogenital or anal conditions; veterinary preparations, namely, veterinary preparations for the treatment of diseases of the circulatory system and diabetes-related diseases, veterinary preparations for treatment of fatty liver and steatohepatitis, veterinary preparations for the treatment of cardiovascular disorders and metabolic disorders, veterinary preparations for the treatment of digestive system disease, veterinary preparations for the treatment of primary biliary cirrhosis, veterinary preparations for the treatment of fatty liver and liver hepatitis and liver cirrhosis, veterinary preparations for the treatment of liver disease, veterinary preparations for the treatment of metabolic disease, veterinary preparations for the prevention and treatment of disorders of the metabolic system, analgesics; veterinary pharmaceutical and biological preparations for the treatment of diseases of the central nervous system, peripheral nervous system, sensory organs, the circulatory system, respiratory system, and the digestive system; veterinary pharmaceutical substances for the treatment of dermatological diseases, allergies and urogenital or anal conditions; sanitary preparations for medical use; anti-inflammatory agents, namely, topical preparations in the form of gels and salves, adhesive skin patches, liquid formulations, cream and sprays, all for relieving pain.

Filing History

CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
Jan 2, 2026 CORR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 25, 2025 FICR
REGISTERED-PRINCIPAL REGISTER
Aug 26, 2025 R.PR
PUBLISHED FOR OPPOSITION
Jun 10, 2025 PUBO
NOTICE OF PUBLICATION
Jun 4, 2025 NPUB
CORRECTION TRANSACTION RECEIVED FROM IB
May 9, 2025 CRCV
APPROVED FOR PUB - PRINCIPAL REGISTER
May 8, 2025 CNSA
ASSIGNED TO EXAMINER
May 2, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
May 1, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 1, 2025 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jul 10, 2024 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Jul 5, 2024 SDRC